Poynard T - Search Results

1

Poynard T, Regimbeau C, Myers RP, Thevenot T, Leroy V, Mathurin P, Opolon P, Zarski JP. Poynard T, et al. Cochrane Database Syst Rev. 2002;2001(1):CD000369. doi: 10.1002/14651858.CD000369. Cochrane Database Syst Rev. 2002. PMID: 11869573 Free PMC article. Review.

2

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.

Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP. Poynard T, et al. Hepatology. 1996 Oct;24(4):778-89. doi: 10.1002/hep.510240405. Hepatology. 1996. PMID: 8855176

3

Treatment of chronic hepatitis C by interferon for longer duration than six months.

Poynard T, Leroy V, Mathurin P, Cohard M, Opolon P, Zarski JP. Poynard T, et al. Dig Dis Sci. 1996 Dec;41(12 Suppl):99S-102S. doi: 10.1007/BF02087883. Dig Dis Sci. 1996. PMID: 9011484 Clinical Trial.

4

Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin.

Thevenot T, Mathurin P, Moussalli J, Perrin M, Plassart F, Blot C, Opolon P, Poynard T. Thevenot T, et al. Among authors: poynard t. J Viral Hepat. 1997 Jul;4(4):243-53. doi: 10.1046/j.1365-2893.1997.00051.x. J Viral Hepat. 1997. PMID: 9278222

5

Management of hepatitis C.

Moussalli J, Opolon P, Poynard T. Moussalli J, et al. Among authors: poynard t. J Viral Hepat. 1998 Mar;5(2):73-82. doi: 10.1046/j.1365-2893.1998.00086.x. J Viral Hepat. 1998. PMID: 9572031 Review.

6

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

Sobesky R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, Ratziu V, Opolon P, Poynard T. Sobesky R, et al. Among authors: poynard t. Gastroenterology. 1999 Feb;116(2):378-86. doi: 10.1016/s0016-5085(99)70135-6. Gastroenterology. 1999. PMID: 9922319

7

Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologie.

Poynard T, Moussalli J, Ratziu V, Thevenot T, Regimbeau C, Opolon P, Horsmans Y, Brenard R, Closon M, Fevery J, Hautekeete M. Poynard T, et al. Acta Gastroenterol Belg. 1998 Oct-Dec;61(4):431-7. Acta Gastroenterol Belg. 1998. PMID: 9923094 Review.

8

Effects of interferon therapy in "non responder" patients with chronic hepatitis C.

Poynard T, Moussali J, Ratziu V, Regimbeau C, Opolon P. Poynard T, et al. J Hepatol. 1999;31 Suppl 1:178-83. doi: 10.1016/s0168-8278(99)80397-3. J Hepatol. 1999. PMID: 10622583 Review.

9

[Treatment and prevention of hepatitis C].

Poynard T, Ratziu V, Benhamou Y, Regimbeau C. Poynard T, et al. Rev Prat. 2000 May 15;50(10):1100-7. Rev Prat. 2000. PMID: 10905096 French.

10

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update.

Thévenot T, Regimbeau C, Ratziu V, Leroy V, Opolon P, Poynard T. Thévenot T, et al. Among authors: poynard t. J Viral Hepat. 2001 Jan;8(1):48-62. doi: 10.1046/j.1365-2893.2001.00271.x. J Viral Hepat. 2001. PMID: 11155152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

608 results

Search Page